SCHEMBL9429932

SCHEMBL9429932

Cc1cccc2c1ncn2-c1ccccc1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
KDM4E B2RXH2 3/20 0.42
PI4KA P42356 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
CYP1A2 P05177 3/20 0.38
CYP17A1 P05093 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
LCK P06239 1/20 0.37
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP2C19 P33261 1/20 0.36
GABRP O00591 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17940741 0.88 PI4KA (0.46) TSHRKDM4EPI4KAPI4K2BPI4K2A
SCHEMBL15389431 0.80 CYP17A1 (0.66) CYP1A2CYP17A1
SCHEMBL9429053 0.79 CYP19A1 (0.37) TSHRKDM4ESMN1; SMN2HIF1AMAPT
SCHEMBL840022 0.78 HTT (0.51) KDM4ECYP1A2L3MBTL1KMT2AALDH1A1
SCHEMBL28252193 0.78 ALDH1A1 (0.44) KDM4ECYP1A2SMN1; SMN2HIF1AMAPT
SCHEMBL9428481 0.75 TSHR (0.46) TSHRKDM4ECYP1A2SMN1; SMN2HIF1A
SCHEMBL17691571 0.73 HTT (0.56) CYP17A1ALDH1A1MAPK1
SCHEMBL17940689 0.72 CYP17A1 (0.39) TSHRCYP17A1LCKGABRA1GABRG2
SCHEMBL17940706 0.72 HTT (0.51) PI4KAPI4K2BPI4K2API4KBGABRA1
SCHEMBL17940726 0.71 HCAR1 (0.41) KDM4ECYP17A1LCKGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374615-A Treating hypertension and congestive heart failure, preventing cardiac hypertrophy E. R. SQUIBB & SONS, INC. (US) 1994-12-20 US disclosed
EP-0547827-A1 Indole and benzimidazole-substituted dihydropyrimidine derivatives useful as A-II receptors antagonists E.R. SQUIBB & SONS, INC. (US) 1993-06-23 EP disclosed
US-5212177-A INDOLE AND BENZIMIDAZOLE-SUBSTITUTED DIHYDROPYRIMIDINE DERIVATIVES E. R. SQUIBB & SONS, INC. (US) 1993-05-18 US disclosed
EP-0488532-A1 Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives E.R. Squibb & Sons, Inc. (US) 1992-06-03 EP disclosed